Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T05:21:00.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    1%
    Check dated 2024-09-25T23:00:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    1%
    Check dated 2024-09-18T17:02:54.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T05:48:46.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new phase II study has been added to evaluate the effectiveness of pembrolizumab in increasing disease-free survival in patients with recurrent squamous cell carcinoma of the head and neck following salvage surgery, while several previous entries, including those related to Ezra Cohen, have been removed.
    Difference
    12%
    Check dated 2024-08-14T00:26:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The status has changed from 'Active, not recruiting' to 'Unknown status'.
    Difference
    0.2%
    Check dated 2024-08-06T22:47:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.